葡萄糖胺：市場動向報告

Abstract

The Glucosamine Market Insight Report analyzes the market by Type and Application at global level and for each of the geographic regions - North America, Europe, China, Asia-Pacific, Latin America and Rest of World. The Glucosamine market is segmented by Type into D-Glucosamine and N-Acetyl-Glucosamine; and by Application into Nutraceutical/Pharmaceutical, Feed Additives, and Nutraceuticals/Pharmaceutical. Business profiles of 60 major companies are discussed in the report. The report serves as a guide to Glucosamine industry covering 239 companies that are engaged in Glucosamine R&D, processing, production, and distribution. The report also covers companies engaged in glucosamine based products. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Projections and estimates are graphically illustrated by geographic region with exclusive graphical representations provided for 285 exhibits.

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

• 1. Introduction
  • Joint Supplements
  • Glucosamine
    • D-Glucosamine Hydrochloride (HCl)
    • Glucosamine Sulphate
    • N-Acetyl-Glucosamine (NAG)
    • Poly N-Acetyl-Glucosamine (Poly NAG)
  • Chondroitin
  • Combination Supplements
  • Chitin and Chitinases
  • Methylsulfonylmethane (MSM, or Dimethylsulfone)
  • Uses of Glucosamine
  • Segmentation of Glucosamine
    • Exhibit 1: Segmentation of Global Glucosamine Market by Type (D-Glucosamine and N-Acetyl-Glucosamine), and by Application (Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and Other) (Graphical Representation Included)
• 2. Global Market Analysis
  • Exhibit 2: Glucosamine (2000-2013) - Global Market Analysis (Historic, Current & Future) in US$ Billion (Graphical Representation Included)
  • Exhibit 3: Glucosamine (2000-2013) - Global Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
  • Market Analysis by Segmentation
  • Analysis by Type
    • Exhibit 4: Glucosamine (2000-2013)-Global Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
    • Exhibit 5: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Exhibit 6: Glucosamine (2000-2013)-Global Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
    • Exhibit 7: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
  • Analysis by Application
    • Exhibit 8: Glucosamine (2000-2013)-Global Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
    • Exhibit 9: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
    • Exhibit 10: Glucosamine (2000-2013)-Global Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
    • Exhibit 11: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • Market Analysis by Geographic Region
    • Analysis by Type
      • D-Glucosamine
        • Exhibit 12: D-Glucosamine (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 13: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 14: D-Glucosamine (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 15: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
      • N-Acetyl-Glucosamine
        • Exhibit 16: N-Acetyl-Glucosamine (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 17: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 18: N-Acetyl-Glucosamine (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 19: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
    • Analysis by Application
      • Nutraceutical/Pharmaceutical
        • Exhibit 20: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 21: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 22: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 23: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
      • Feed Additives
        • Exhibit 24: Glucosamine in Feed Additives (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 25: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 26: Glucosamine in Feed Additives (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 27: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
      • Food Ingredients
        • Exhibit 28: Glucosamine in Food Ingredients (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 29: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 30: Glucosamine in Food Ingredients (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 31: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
      • Other
        • Exhibit 32: Glucosamine in Other (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
        • Exhibit 33: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • Exhibit 34: Glucosamine in Other (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
        • Exhibit 35: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
        • List Of Major Global Companies
• 3. Regional Market Analysis
  • North America
    • Exhibit 36: Glucosamine (2000-2013) - North American Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 37: Glucosamine (2000-2013) - North American Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • Major Companies In North America
      • Aim Companies (The) (USA)
      • AniMed (USA)
      • Bio-Alternatives (USA)
      • Cargill, Inc. (USA)
      • DTC Health, Inc. (USA)
      • JFC Technologies (USA)
      • NUPRO (USA)
      • Pacific Rainbow International Inc. (USA)
      • Perrigo Company (USA)
      • Pharmline Inc. (USA)
      • SCOLR Pharma, Inc. (USA)
      • Stina Resources Ltd. (Canada)
      • Synflex America Inc. (USA)
      • TSI Health Sciences (USA)
      • Unipharm, Inc. (USA)
      • Zylera Pharmaceuticals (USA)
    • Analysis by Type
      • D-Glucosamine
        • Exhibit 38: D-Glucosamine (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 39: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 40: D-Glucosamine (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 41: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
      • N-Acetyl-Glucosamine
        • Exhibit 42: N-Acetyl-Glucosamine (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 43: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 44: N-Acetyl-Glucosamine (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 45: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
    • Analysis by Application
      • Nutraceutical/Pharmaceutical
        • Exhibit 46: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 47: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 48: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 49: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
      • Feed Additives
        • Exhibit 50: Glucosamine in Feed Additives (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 51: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 52: Glucosamine in Feed Additives (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 53: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
      • Food Ingredients
        • Exhibit 54: Glucosamine in Food Ingredients (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 55: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 56: Glucosamine in Food Ingredients (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 57: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
      • Other
        • Exhibit 58: Glucosamine in Other (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
        • Exhibit 59: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
        • Exhibit 60: Glucosamine in Other (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
        • Exhibit 61: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
  • Europe
    • Exhibit 62: Glucosamine (2000-2013) - European Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 63: Glucosamine (2000-2013) - European Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • Major Companies In Europe
      • Ardern Healthcare Ltd. (UK)
      • Auromed Ltd. (UK)
      • Bioiberica (Spain)
      • Kraeber GmbH & Co. (Germany)
      • Navamedic ASA (Norway)
      • Norbrook Laboratories Ltd. (UK)
      • Norwegian Chitosan Ltd. (Norway)
      • Rottapharm SpA (Italy)
      • Seven Seas Ltd. (UK)
      • William Ransom & Son PLC. (UK)
    • Analysis by Type
      • D-Glucosamine
        • Exhibit 64: D-Glucosamine (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
        • Exhibit 65: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 66: D-Glucosamine (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
        • Exhibit 67: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
      • N-Acetyl-Glucosamine
        • Exhibit 68: N-Acetyl-Glucosamine (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
        • Exhibit 69: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 70: N-Acetyl-Glucosamine (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
        • Exhibit 71: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
    • Analysis by Application
      • Nutraceutical/Pharmaceutical
        • Exhibit 72: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
        • Exhibit 73: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 74: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
        • Exhibit 75: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
      • Feed Additives
        • Exhibit 76: Glucosamine in Feed Additives (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
        • Exhibit 77: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 78: Glucosamine in Feed Additives (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
        • Exhibit 79: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
      • Food Ingredients
        • Exhibit 80: Glucosamine in Food Ingredients (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
        • Exhibit 81: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 82: Glucosamine in Food Ingredients (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
        • Exhibit 83: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
      • Other
        • Exhibit 84: Glucosamine in Other (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic in US$ Million (Graphical Representation Included)
        • Exhibit 85: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
        • Exhibit 86: Glucosamine in Other (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic in Metric Tons (Graphical Representation Included)
        • Exhibit 87: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
  • China
    • Exhibit 88: Glucosamine (2000-2013) -Chinese Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 89: Glucosamine (2000-2013) -Chinese Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • Major Companies In China
      • A & Z Food Additives Co., Ltd.
      • Dongying Development Zone Marine Organism Chemical Co., Ltd.
      • Franken Biochem Co., Ltd
      • HangZhou Peak Chemicals Company Ltd. (PeakChem)
      • Hebei Sanxin Industry Group Co., Ltd.
      • Hygieia Health Products
      • Lyotne Enterprise, Inc.
      • PrimePharm Health Co., Ltd
      • SEPAC Co., Ltd
      • Shandong Rongcheng Luyang Chemical Co., Ltd
      • Shandong Yibao Biologics Co., Ltd.
      • Shine Star (Hubei) Biological Engineering Co., Ltd.
      • Sinochem Qingdao Co., Ltd.
      • SinoSource Enterprise Co., Ltd
      • Sinoway International (Jiangsu) Co., Ltd
      • Taizhou Candorly Sea Biochemical & Health Products Co., Ltd.
      • Wellable Group Marine Biological & Chemical Co., Ltd.
      • Zhejiang Aoxing Biotechnology Co., Ltd
      • Zhejiang New Fuda Pharm & Chem Co., Ltd
      • Zhejiang Yongyue Ocean Biology Co., Ltd.
      • ZMC
  • Asia-Pacific
    • Exhibit 90: Glucosamine (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 91: Glucosamine (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • Major Companies In Asia-Pacific
      • Astamed Healthcare (I) Pvt. Ltd. (India)
      • Bayir Chemicals (India)
      • Bioprex Labs (India)
      • Biosourcing.com (P) Ltd. (India)
      • Coastal Laboratories (India)
      • Exotic Naturals (India)
      • Pharmed Medicare (India)
      • Sai Gluco Pharma (India)
      • Sai Sukush Inc. (India)
      • Shreeji Pharma International (India)
      • Shubhmets (India)
      • Wanbury Ltd. (India)
      • Yaizu Suisankagaku Industry Co.,Ltd. (Japan)
    • Analysis by Type
      • D-Glucosamine
        • Exhibit 92: D-Glucosamine (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 93: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 94: D-Glucosamine (2000-2013) - Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of ^Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 95: D-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
      • N-Acetyl-Glucosamine
        • Exhibit 96: N-Acetyl-Glucosamine (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 97: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 98: N-Acetyl-Glucosamine (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 99: N-Acetyl-Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
    • Analysis by Application
      • Nutraceutical/Pharmaceutical
        • Exhibit 100: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 101: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 102: Glucosamine in Nutraceutical/Pharmaceutical (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 103: Glucosamine in Nutraceutical/Pharmaceutical (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
      • Feed Additives
        • Exhibit 104: Glucosamine in Feed Additives (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 105: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 106: Glucosamine in Feed Additives (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 107: Glucosamine in Feed Additives (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
      • Food Ingredients
        • Exhibit 108: Glucosamine in Food Ingredients (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 109: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 110: Glucosamine in Food Ingredients (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 111: Glucosamine in Food Ingredients (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
      • Other
        • Exhibit 112: Glucosamine in Other (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
        • Exhibit 113: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
        • Exhibit 114: Glucosamine in Other (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
        • Exhibit 115: Glucosamine in Other (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
  • Rest of World
    • Exhibit 116: Glucosamine (2000-2013) - Rest of World Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 117: Glucosamine (2000-2013) - Rest of World Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)

III. PRODUCT TECHNOLOGY/RESEARCH

• Introduction
  • Glucosamine
  • Biochemistry
  • Health Effects
  • Dosage
  • Safety
  • Bioavailability and Pharmacokinetics
  • Mechanism of Action
  • Anti-Allergic Glucosamine
  • Applications
  • Glucosamine Growth Trends - Global Markets
    • Exhibit 118: Global Market for Glucosamine: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Segmentation of Glucosamine
• Segmentation by Type
  • Growth Trends - Global Market for Glucosamine by Type
    • Exhibit 119: Global Market for Glucosamine by Type (N-Acetyl-Glucosamine and D-Glucosamine) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
• D-Glucosamine
  • Growth Trends - Global Market for D-Glucosamine
    • Exhibit 120: Global Market for D-Glucosamine: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Fermentation Process of Glucosamine
  • Cell-free Production of Glucosamine
• N-Acetyl-Glucosamine
  • Growth Trends - Global Market for N-Acetyl-Glucosamine
    • Exhibit 121: Global Market for N-Acetyl-Glucosamine: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • N-Acetyl-Glucosamine
  • Fermentation Process of N-Acetyl-Glucosamine
  • N-Acetyl-Glucosamine Manufacturing Technology
    • The Process
    • Verification of N-Acetyl-Glucosamine Production
• Segmentation by Application
  • Growth Trends - Global Market for Glucosamine by Application
    • Exhibit 122: Global Market for Glucosamine by Application (Food Ingredients, Other, Feed Additives and Nutraceutical/Pharmaceutical) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
• Nutraceutical/Pharmaceutical
  • Growth Trends - Global Market for Glucosamine in Nutraceutical/Pharmaceutical
    • Exhibit 123: Global Market for Glucosamine by Application in Nutraceutical/Pharmaceutical: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Glucosamine: Uses and Health Benefits
    • Knee Osteoarthritis (Mild to Moderate)
    • Osteoarthritis (General)
    • Chronic Venous Insufficiency
    • Inflammatory Bowel Disease (Crohn' s Disease, Ulcerative Colitis)
    • Rheumatoid Arthritis
    • Temporomandibular Joint (TMJ) Disorders
    • Uses Based on Tradition or Theory
    • The Usage of Glucosamine for Arthritis and Hip Dysplasia
• Feed Additives
  • Growth Trends - Global Market for Glucosamine in Feed Additives
    • Exhibit 124: Global Market for Glucosamine by Application in Feed Additives: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Glucosamine for Animals
• Food Ingredients
  • Growth Trends - Global Market for Glucosamine in Food Ingredients
    • Exhibit 125: Global Market for Glucosamine by Application in Food Ingredients: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Vegetarian Glucosamine
    • Source
    • Manufacture
    • Safety
  • Glucosamine as a Food Ingredient
  • GreenGrown Glucosamine
  • GlucosaGreen
• Other
  • Growth Trends - Global Market for Glucosamine in Other Application
    • Exhibit 126: Global Market for Glucosamine by Application in Other: Geographic Regions (North America, Europe, Asia-Pacific, China and Rest of World) Ranked by Projected CAGR for 2000 through 2013 (Graphical Representation Included)
  • Application of N-Acetyl-Glucosamine in Cosmetology
  • Rules and Regulations for Manufacture, Distribution and Labeling of Glucosamine
    • Regulation in Japan
      • Deregulation
      • Foods with Health Claim Act
      • Foods for Specified Health Use (FOSHU)
      • Foods Not Allowed to Have Health Claims
      • Health Promotion Law
      • Other Laws & Regulations that Comply to Manufacture, Distribute and to Market the Nutritional Supplements in Japan
      • Nutritional Supplements Certification Program
      • Product Specification and Label
    • Regulation in Europe
      • Novel Food Assessments
      • Submitting an Application
      • ACNFP Guidelines for the Presentation of Data
        • Introduction
        • Contents of the Application Dossier
      • The European Parliament and the Council of the European Union,
      • Regulation (EC) No 258/97

IV. MARKET DYNAMICS

• Market Overview
• 1. Global Market Analysis
  • Exhibit 127: Glucosamine (2000-2013) - Global Market Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in US$ Million (Graphical Representation Included)
  • Exhibit 128: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
  • Exhibit 129: Glucosamine (2000-2013) - Global Volume Analysis (Historic, Current & Future) by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World in Metric Tons (Graphical Representation Included)
  • Exhibit 130: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Geographic Region for North America, Europe, China, ^Asia-Pacific and Rest of World (Graphical Representation Included)
  • Analysis by Type
    • Exhibit 131: Glucosamine (2000-2013)-Global Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
    • Exhibit 132: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Exhibit 133: Glucosamine (2000-2013)-Global Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
    • Exhibit 134: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
  • Analysis by Application
    • Exhibit 135: Glucosamine (2000-2013)-Global Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
    • Exhibit 136: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
    • Exhibit 137: Glucosamine (2000-2013)-Global Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
    • Exhibit 138: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Global Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
    • Exhibit 139: Major Companies in Glucosamine Industry - Production Capacity
    • Exhibit 140: Major Companies in Glucosamine Industry- Market Share
    • Exhibit 141: US Glucosamine Price Estimates (2001-2005)
• 2. Major Global Companies In Glucosamine Industry
  • A & Z Food Additives Co., Ltd. (China)
  • Aim Companies (The) (USA)
  • AniMed (USA)
  • Ardern Healthcare Ltd. (UK)
  • Astamed Healthcare (I) Pvt. Ltd. (India)
  • Auromed Ltd. (UK)
  • Bayir Chemicals (Indi a)
  • Bio-Alternatives (USA)
  • Bioiberica (Spain)
  • Bioprex Labs (India)
  • Biosourcing.com (P) Ltd. (India)
  • Cargill, Inc. (USA)
  • Coastal Laboratories (India)
  • Dongying Development Zone Marine Organism Chemical Co., Ltd. (China)
  • DTC Health, Inc. (USA)
  • Exotic Naturals (India)
  • Franken Biochem Co., Ltd. (China)
  • HangZhou Peak Chemicals Company Ltd. (PeakChem) (China)
  • Hebei Sanxin Industry Group Co., Ltd. (China)
  • Hygieia Health Products (Hong Kong)
  • JFC Technologies (USA)
  • Kraeber GmbH & Co. (Germany)
  • Lyotne Enterprise, Inc. (Taiwan)
  • Navamedic ASA (Norway)
  • Norbrook Laboratories Ltd. (UK)
  • Norwegian Chitosan Ltd. (Norway)
  • NUPRO (USA)
  • Pacific Rainbow International Inc. (USA)
  • Perrigo Company (USA)
  • Pharmed Medicare (India)
  • Pharmline Inc. (USA)
  • PrimePharm Health Co., Ltd.(China)
  • Rottapharm SpA (Italy)
  • Sai Gluco Pharma (India)
  • Sai Sukush Inc. (India)
  • SCOLR Pharma, Inc. (USA)
  • SEPAC Co., Ltd. (China)
  • Seven Seas Ltd. (UK)
  • Shandong Rongcheng Luyang Chemical Co., Ltd. (China)
  • Shandong Yibao Biologics Co., Ltd. (China)
  • Shine Star (Hubei) Biological Engineering Co., Ltd. (China)
  • Shreeji Pharma International (India)
  • Shubhmets (India)
  • Sinochem Qingdao Co., Ltd. (China)
  • SinoSource Enterprise Co., Ltd. (China)
  • Sinoway International (Jiangsu) Co., Ltd. (China)
  • Stina Resources Ltd. (Canada)
  • Synflex America Inc. (USA)
  • Taizhou Candorly Sea Biochemical & Health Products Co., Ltd. (China)
  • TSI Health Sciences (USA)
  • Unipharm, Inc. (USA)
  • Wanbury Ltd. (India)
  • Wellable Group Marine Biological & Chemical Co., Ltd. (China)
  • William Ransom & Son PLC. (UK)
  • Yaizu Suisankagaku Industry Co.,Ltd. (Japan)
  • Zhejiang Aoxing Biotechnology Co., Ltd. (China)
  • Zhejiang New Fuda Pharm & Chem Co., Ltd. (China)
  • Zhejiang Yongyue Ocean Biology Co., Ltd. (China)
  • ZMC (China)
  • Zylera Pharmaceuticals (USA)
• 3. Major Activities in Glucosamine Industry
  • William Ransom Unveils the Alateris
  • Navamedic Introduces Mobilat Glucosamin in Germany
  • William Ransom to Supply Navamedic' s Glucomed, the only Approved Glucosamine
  • Products Exclusively for 10 years in UK
  • Cargill Attains GRAS Status for REGENASURE® Glucosamine
  • Zylera Pharmaceuticals Introduces RELAMINE for Osteoarthritis Treatment
  • Glucomed/Flexove Attains EU Approval
  • Navamedic Signs an Agreement with PacificPharm for Supplying Glucomed in Korea
  • Zylera Commercializes RELAMINE
  • Lytone Purchases Chitin from ChitiNor of Navamedic
  • Navamedic Signs an Agreement with Nergård Group
• 4. Regional Market Analysis
  • A. North America
    • Exhibit 142: Glucosamine (2000-2013) -North American Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 143: Glucosamine (2000-2013) -North American Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • List of Major Companies In North America
    • Analysis by Geographic Region
      • Exhibit 144: Glucosamine (2000-2013) - North American Market Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation Included)
      • Exhibit 145: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation Included)
      • Exhibit 146: Glucosamine (2000-2013) - North American Volume Analysis (Historic, Current & Future) by Geographic Region for United States and Canada in Metric Tons (Graphical Representation Included)
      • Exhibit 147: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Geographic Region for United States and Canada (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 148: Glucosamine (2000-2013)-North American Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 149: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 150: Glucosamine (2000-2013)-North American Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 151: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 152: Glucosamine (2000-2013)- North American Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 153: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 154: Glucosamine (2000-2013)- North American Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 155: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of North American Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • A1. United States
    • Analysis by Type
      • Exhibit 156: Glucosamine (2000-2013)-United States Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 157: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United States Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 158: Glucosamine (2000-2013)-United States Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 159: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United States Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 160: Glucosamine (2000-2013)- United States Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 161: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United States Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 162: Glucosamine (2000-2013)- United States Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 163: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United States Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • A2. Canada
    • Analysis by Type
      • Exhibit 164: Glucosamine (2000-2013)-Canadian Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 165: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Canadian Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 166: Glucosamine (2000-2013)-Canadian Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 167: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Canadian Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 168: Glucosamine (2000-2013)- Canadian Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 169: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Canadian Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 170: Glucosamine (2000-2013)- Canadian Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 171: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Canadian Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B. Europe
    • Exhibit 172: Glucosamine (2000-2013) - European Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 173: Glucosamine (2000-2013) - European Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • List Of Major Companies In Europe
    • Analysis by Geographic Region
      • Exhibit 174: Glucosamine (2000-2013) - European Market Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in US$ Million (Graphical Representation Included)
      • Exhibit 175: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
      • Exhibit 176: Glucosamine (2000-2013) - European Volume Analysis (Historic, Current & Future) by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe in Metric Tons (Graphical Representation Included)
      • Exhibit 177: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Geographic Region for United Kingdom, Germany, Spain, Czech Republic and Rest of Europe (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 178: Glucosamine (2000-2013)-European Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 179: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 180: Glucosamine (2000-2013)-European Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 181: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 182: Glucosamine (2000-2013)- European Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 183: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 184: Glucosamine (2000-2013)- European Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 185: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of European Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B1. United Kingdom
    • Analysis by Type
      • Exhibit 186: Glucosamine (2000-2013)-United Kingdom Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 187: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United Kingdom Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 188: Glucosamine (2000-2013)-United Kingdom Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 189: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United Kingdom Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 190: Glucosamine (2000-2013)- United Kingdom Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 191: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United Kingdom Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 192: Glucosamine (2000-2013)- United Kingdom Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 193: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of the United Kingdom Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B2. Germany
    • Analysis by Type
      • Exhibit 194: Glucosamine (2000-2013)-German Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 195: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of German Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 196: Glucosamine (2000-2013)-German Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 197: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of German Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 198: Glucosamine (2000-2013)- German Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients *Other in US$ Million (Graphical Representation Included)
      • Exhibit 199: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of German Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 200: Glucosamine (2000-2013)- German Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 201: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of German Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B3. Spain
    • Analysis by Type
      • Exhibit 202: Glucosamine (2000-2013)-Spanish Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 203: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Spanish Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 204: Glucosamine (2000-2013)-Spanish Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 205: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Spanish Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 206: Glucosamine (2000-2013)- Spanish Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 207: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Spanish Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 208: Glucosamine (2000-2013)- Spanish Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 209: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Spanish Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B4. Czech Republic
    • Analysis by Type
      • Exhibit 210: Glucosamine (2000-2013)-Czech Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 211: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Czech Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 212: Glucosamine (2000-2013)-Czech Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 213: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Czech Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 214: Glucosamine (2000-2013)- Czech Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 215: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Czech Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 216: Glucosamine (2000-2013)- Czech Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 217: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Czech Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • B5. Rest of Europe
    • Analysis by Type
      • Exhibit 218: Glucosamine (2000-2013)-Rest of Europe Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 219: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 220: Glucosamine (2000-2013)-Rest of Europe Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 221: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Europe Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 222: Glucosamine (2000-2013)- Rest of Europe Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 223: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Europe Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 224: Glucosamine (2000-2013)- Rest of Europe Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 225: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Europe Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • C. China
    • Exhibit 226: Glucosamine (2000-2013) -Chinese Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 227: Glucosamine (2000-2013) -Chinese Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • List Of Major Companies In China (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 228: Glucosamine (2000-2013)-Chinese Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 229: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Chinese Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 230: Glucosamine (2000-2013)-Chinese Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 231: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Chinese Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application (Graphical Representation Included)
      • Exhibit 232: Glucosamine (2000-2013)- Chinese Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 233: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Chinese Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 234: Glucosamine (2000-2013)- Chinese Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 235: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Chinese Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • D. Asia-Pacific
    • Exhibit 236: Glucosamine (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 237: Glucosamine (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • List of Major Companies In Asia-Pacific
    • Analysis by Geographic Region
      • Exhibit 238: Glucosamine (2000-2013) - ^Asia-Pacific Market Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
      • Exhibit 239: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Market Value by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
      • Exhibit 240: Glucosamine (2000-2013) - ^Asia-Pacific Volume Analysis (Historic, Current & Future) by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific in Metric Tons (Graphical Representation Included)
      • Exhibit 241: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of ^Asia-Pacific Volume by Geographic Region for Japan, Australia, India and Rest of Asia-Pacific (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 242: Glucosamine (2000-2013)-Asia-Pacific Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 243: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 244: Glucosamine (2000-2013)-Asia-Pacific Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 245: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Asia-Pacific Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 246: Glucosamine (2000-2013)- Asia-Pacific Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 247: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Asia-Pacific Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 248: Glucosamine (2000-2013)- Asia-Pacific Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 249: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Asia-Pacific Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • D1. Japan
    • Analysis by Type
      • Exhibit 250: Glucosamine (2000-2013)-Japanese Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 251: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Japanese Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 252: Glucosamine (2000-2013)-Japanese Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 253: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Japanese Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 254: Glucosamine (2000-2013)- Japanese Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 255: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Japanese Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 256: Glucosamine (2000-2013)- Japanese Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 257: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Japanese Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • D2. Australia
    • Analysis by Type
      • Exhibit 258: Glucosamine (2000-2013)-Australian Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 259: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Australian Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 260: Glucosamine (2000-2013)-Australian Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 261: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Australian Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 262: Glucosamine (2000-2013)- Australian Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 263: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Australian Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 264: Glucosamine (2000-2013)- Australian Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 265: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Australian Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • D3. India
    • Analysis by Type
      • Exhibit 266: Glucosamine (2000-2013)-Indian Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 267: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Indian Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 268: Glucosamine (2000-2013)-Indian Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 269: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Indian Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 270: Glucosamine (2000-2013)- Indian Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 271: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Indian Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 272: Glucosamine (2000-2013)- Indian Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 273: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Indian Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • D4. Rest of Asia-Pacific
    • Analysis by Type
      • Exhibit 274: Glucosamine (2000-2013)-Rest of Asia-Pacific Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 275: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 276: Glucosamine (2000-2013)-Rest of Asia-Pacific Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 277: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 278: Glucosamine (2000-2013)- Rest of Asia-Pacific Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 279: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 280: Glucosamine (2000-2013)- Rest of Asia-Pacific Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 281: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of Asia-Pacific Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
  • E. Rest of World
    • Exhibit 282: Glucosamine (2000-2013) - Rest of World Market Analysis (Historic, Current & Future) in US$ Million (Graphical Representation Included)
    • Exhibit 283: Glucosamine (2000-2013) - Rest of World Volume Analysis (Historic, Current & Future) in Metric Tons (Graphical Representation Included)
    • Analysis by Type
      • Exhibit 284: Glucosamine (2000-2013)- Rest of World Market Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million (Graphical Representation Included)
      • Exhibit 285: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of World Market Value by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
      • Exhibit 286: Glucosamine (2000-2013)- Rest of World Volume Analysis (Historic, Current & Future) by Type for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons (Graphical Representation Included)
      • Exhibit 287: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown o Rest of World Volume by Type for D-Glucosamine and N-Acetyl-Glucosamine (Graphical Representation Included)
    • Analysis by Application
      • Exhibit 288: Glucosamine (2000-2013)- Rest of World Market Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in US$ Million (Graphical Representation Included)
      • Exhibit 289: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of World Market Value by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
      • Exhibit 290: Glucosamine (2000-2013)- Rest of World Volume Analysis (Historic, Current & Future) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other in Metric Tons (Graphical Representation Included)
      • Exhibit 291: Glucosamine (2000, 2006 and 2013) - Percentage Breakdown of Rest of World Volume by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and *Other (Graphical Representation Included)
• 5. Industry Outlook

V. CORPORATE DIRECTORY